Same Indication

Lenvatinib Mesylate vs Trastuzumab

Lenvatinib Mesylate vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Lenvatinib Mesylate and Trastuzumab.

Mechanism of Action

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Trastuzumab β€” 28 days.

Chemical Properties

Type: Lenvatinib Mesylate β€” Small molecule; Trastuzumab β€” Antibody.